Invention Grant
- Patent Title: Combination therapy for a stable and long term engraftment
-
Application No.: US16508325Application Date: 2019-07-11
-
Publication No.: US11497776B2Publication Date: 2022-11-15
- Inventor: Yair Reisner , Esther Bachar-Lustig
- Applicant: Yeda Research and Development Co. Ltd.
- Applicant Address: IL Rehovot
- Assignee: Yeda Research and Development Co. Ltd.
- Current Assignee: Yeda Research and Development Co. Ltd.
- Current Assignee Address: IL Rehovot
- Main IPC: A61K35/28
- IPC: A61K35/28 ; A61K35/17 ; A61K35/22 ; A61K35/38 ; A61K35/39 ; A61K35/407 ; A61K35/42 ; A61K31/675 ; A61K35/34 ; A61K35/36 ; C12N5/00 ; A61K31/198 ; A61K31/255 ; A61K31/7076 ; A61P37/06 ; A61P37/02 ; A61K31/661 ; A61K39/395 ; A61K39/00 ; A61K35/12

Abstract:
A method of treating a subject in need of a non-syngeneic cell or tissue graft is disclosed. The method comprising: (a) transplanting into a subject a dose of T cell depleted immature hematopoietic cells, wherein the T cell depleted immature hematopoietic cells comprise less than 5×105 CD3+ T cells per kilogram body weight of the subject, and wherein the dose comprises at least about 5×106 CD34+ cells per kilogram body weight of the subject; and subsequently (b) administering to the subject a therapeutically effective amount of cyclophosphamide, wherein the therapeutically effective amount comprises 25-200 mg per kilogram body weight, thereby treating the subject.
Public/Granted literature
- US20190328793A1 COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT Public/Granted day:2019-10-31
Information query
IPC分类: